Isodiol International Inc Share Price Canadian Securities Exchange
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 19.14M 26.17M 1.59B | Sales 2019 | 22.25M 30.43M 1.85B | Capitalization | 49.96M 68.33M 4.16B |
---|---|---|---|---|---|
Net income 2018 | -36M -49.24M -3B | Net income 2019 | -126M -172M -10.5B | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 15.55M 21.27M 1.3B | Net Debt 2019 | 5.22M 7.14M 435M | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/19/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Director/Board Member | - | 21/18/21 |
1st Jan change | Capi. | |
---|---|---|
+26.93% | 5.55B | |
-33.55% | 3.52B | |
-3.74% | 3.03B | |
-26.09% | 2.59B | |
-10.93% | 2.28B | |
+41.50% | 1.88B | |
+41.84% | 1.46B | |
+47.62% | 1.42B | |
-28.07% | 1.26B |